Found 223 results
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is Y  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
L. E. Bermudez and Young, L. S., Tumor necrosis factor alpha stimulates mycobactericidal/mycobacteriostatic activity in human macrophages by a protein kinase C-independent pathway., Cellular immunology, vol. 144, no. 2, pp. 258-68, 1992.
L. E. Bermudez and Young, L. S., Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex., Journal of immunology (Baltimore, Md. : 1950), vol. 140, no. 9, pp. 3006-13, 1988.
U. M. Le, Yanasarn, N., Löhr, C. V., Fischer, K. A., and Cui, Z., Tumor chemo-immunotherapy using gemcitabine and a synthetic dsRNA., Cancer biology & therapy, vol. 7, no. 3, pp. 440-7, 2008.
L. E. Bermudez, Stevens, P., Kolonoski, P., Wu, M., and Young, L. S., Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor., Journal of immunology (Baltimore, Md. : 1950), vol. 143, no. 9, pp. 2996-3000, 1989.
L. E. Bermudez, Yau-Young, A. O., Lin, J. P., Cogger, J., and Young, L. S., Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides., The Journal of infectious diseases, vol. 161, no. 6, pp. 1262-8, 1990.
L. E. Bermudez, Yau-Young, A. O., Lin, J. P., Cogger, J., and Young, L. S., Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides., The Journal of infectious diseases, vol. 161, no. 6, pp. 1262-8, 1990.
E. Fu, Ramsey, S. A., Kauffman, P., Lutz, B., and Yager, P., Transport in two-dimensional paper networks., Microfluid Nanofluidics, vol. 10, no. 1, pp. 29-35, 2011.
B. P. Dolan, Bennink, J. R., and Yewdell, J. W., Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands., Cellular and molecular life sciences : CMLS, vol. 68, no. 9, pp. 1481-9, 2011.
R. R. Rodrigues, Gurung, M., Li, Z., Garcia-Jaramillo, M., Greer, R., Gaulke, C., Bauchinger, F., You, H., Pederson, J. W., Vasquez-Perez, S., White, K. D., Frink, B., Philmus, B., Jump, D. B., Trinchieri, G., Berry, D., Sharpton, T. J., Dzutsev, A., Morgun, A., and Shulzhenko, N., Transkingdom interactions between Lactobacilli and hepatic mitochondria attenuate western diet-induced diabetes., Nat Commun, vol. 12, no. 1, p. 101, 2021.
G. C. Perng, Esmaili, D., Slanina, S. M., Yukht, A., Ghiasi, H., Osorio, N., Mott, K. R., Maguen, B., Jin, L., Nesburn, A. B., and Wechsler, S. L., Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits., Journal of virology, vol. 75, no. 19, pp. 9018-28, 2001.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice., Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment., Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.
S
S. Soonthornvacharin, Rodriguez-Frandsen, A., Zhou, Y., Galvez, F., Huffmaster, N. J., Tripathi, S., Balasubramaniam, V. R. M. T., Inoue, A., de Castro, E., Moulton, H. M., Stein, D. A., Sánchez-Aparicio, M. Teresa, De Jesus, P. D., Nguyen, Q., König, R., Krogan, N. J., García-Sastre, A., Yoh, S. M., and Chanda, S. K., Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation., Nat Microbiol, vol. 2, p. 17022, 2017.
G. Carter, Young, L. S., and Bermudez, L. E., A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation., Antimicrobial agents and chemotherapy, vol. 48, no. 12, pp. 4907-10, 2004.
L. E. Bermudez, Inderlied, C., and Young, L. S., Stimulation with cytokines enhances penetration of azithromycin into human macrophages., Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
D. S. Youngblood, Hatlevig, S. A., Hassinger, J. N., Iversen, P. L., and Moulton, H. M., Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells., Bioconjugate chemistry, vol. 18, no. 1, pp. 50-60, 2007.
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease., Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
J. - Da Lin, Nishi, H., Poles, J., Niu, X., Mccauley, C., Rahman, K., Brown, E. J., Yeung, S. T., Vozhilla, N., Weinstock, A., Ramsey, S. A., Fisher, E. A., and Loke, P. 'ng, Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression., JCI Insight, vol. 4, no. 4, 2019.

Pages